India’s Jubilant, France’s Guerbet In Device Distribution Deal In Europe
This article was originally published in PharmAsia News
Executive Summary
Jubilant Organosys of India and France's Guerbet have signed an agreement to have the French firm distribute Jubilant's nuclear-medicine products in Europe. Jubilant's diagnostic and therapy imaging devices are intended to complement MRI and X-ray scans. The head of Jubilant said the deal enables it to expand its business in regulated markets while gaining a greater market share in Europe. The deal was made through Jubilant's subsidiary, Draximage. (Click here for more
You may also be interested in...
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.
Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116
As Merck’s 21-valent vaccine approaches its 17 June user fee goal, the US CDC’s vaccine committee is looking at new adult age-based recommendations and bracing for a full pipeline led by GSK’s 24-valent candidate.